S5E3: What's Next for Lipoprotein(a)?

(904) 998-0854

Podcasts

S5E3: What’s Next for Lipoprotein(a)? Insights from an Expert Discussion Group

Alan Brown, MD, FACC, MNLA · Jessica M. Pena, MD, MPH, FNLA · Marlys Koschinsky, PhD, FNLA

Posted October 4, 2024

Alan S. Brown, MD, FACC, MNLA

Specialist in Clinical Lipidology
Professor of Cardiovascular Medicine
Wake Forest School of Medicine

Marlys L. Koschinsky, PhD, FNLA

Scientist, Robarts Research Institute
Professor, Dept. of Physiology & Pharmacology, Schulich School of Medicine & Dentistry
The University of Western Ontario London

Jessica M. Pena, MD, MPH, FNLA

Director, HeartHealth, Dalio Institute of Cardiovascular Imagining
Associate Professor of Clinical Medicine and Medicine in Clinical Radiology
Assistant Dean for Admissions Weill Cornell Medicine and New York Presbyterian Hospital

Listen to Dr. Brown discuss with Dr. Koschinsky and Dr. Pena about how this important lipoprotein and potent cardiovascular risk marker is transitioning from the purview of the specialist to that of the general practitioner. Its clinical adoption as an important test is increasing in momentum.

Additional Materials: Journal Article

Lp(a)

Recent Podcasts

Podcasts

S5E3: What’s Next for Lipoprotein(a)? Insights from an Expert Discussion Group

Recent Podcasts

Episode 6: Industry Innovations: Guidelines in Action

Episode 5: Statin Intolerance in Focus: Navigating Side Effects, Patient Concerns, and the Path to Optimal LDL Lowering

S7E8: Thinking Long-Term: LDL Exposure, Longevity Medicine, and the Future of Cardiovascular Prevention

S1E1: Clinical Pearls on Provider Methods for Obtaining Prior Authorizations for PCSK9i

S1E2: General Gaps in FH Care